Cargando…
Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review
BACKGROUND: Neurological immune-related adverse events (nirAEs) are rare toxicities of immune-checkpoint inhibitors (ICI). With the increase use of ICIs, incidence of nirAEs is growing, among which ICI related MG (irMG) is causing high fatality rate. Given the limited evidence, data from a large coh...
Autores principales: | Shi, Jiayu, Tan, Ying, Huang, Yangyu, Li, Ke, Yan, Jingwen, Guan, Yuzhou, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022009/ https://www.ncbi.nlm.nih.gov/pubmed/35463153 http://dx.doi.org/10.3389/fneur.2022.858628 |
Ejemplares similares
-
Patients With Myasthenia Gravis With Acute Onset of Dyspnea: Predictors of Progression to Myasthenic Crisis and Prognosis
por: Huang, Yangyu, et al.
Publicado: (2021) -
Treatment of insomnia in myasthenia gravis—A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia
por: Yan, Jingwen, et al.
Publicado: (2023) -
Iron metabolism patterns in non-anemic patients with myasthenia gravis: A cross-sectional and follow-up study
por: Li, Ke, et al.
Publicado: (2022) -
Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study
por: Tan, Ying, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
por: Huang, Yi-Te, et al.
Publicado: (2020)